Findings from a new study claim that proton therapy leads to a significantly lower risk of side effects severe enough to lead to unplanned hospitalizations for cancer patients when compared to traditional radiation. Although cure rates between the proton therapy and radiation groups remain almost identical, the study conducted at the Perelman School of Medicine […]
Varian Medical spending extra on Endocare and Alicon purchase
Radiation oncology treatments and software maker Varian Medical Systems (NYSE:VAR) announced today that it updated its previously reported GAAP preliminary financial results for the fourth quarter and fiscal 2019. Earlier this week, the company uncovered new information and determined that the financial performance of its recently acquired Endocare and Alicon business was better than previously understood […]
Varian gets a jolt from meet-and-beat fiscal numbers, 202 forecast
Varian Medical (NYSE:VAR) got a jolt today from its fiscal fourth-quarter and full-year results, which met the consensus earnings forecast and topped Wall Street’s expectations for sales, and added a pair of names to its senior leadership roster. Palo Alto, Calif.-based radiotherapy device maker posted profits of $89.3 million, or 97¢ per share, on sales of […]
U.S. exempts more Chinese medtech products from tariffs
The U.S. has exempted another 18 medical devices or device components from the 25% tariffs imposed on Chinese goods by the Trump administration. The new list includes ultrasound, X-ray, MRI and infusion equipment. The Office of the U.S. Trade Representative (USTR) said the new exclusions are retroactive to August 23, 2018, when additional tariffs went […]
Varian wins tariff exclusion for radiotherapy components
Varian Medical (NYSE:VAR) today said the U.S. Trade Representative granted exclusion of its radiotherapy system components from China in the latest tariffs. Palo Alto, Calif.-based Varian said components sourced from China for its linear accelerators manufactured in the U.S. were granted exemption from Section 301 of the tariffs. The exemption took place on Sept. 20. “We […]
Varian backs Oncora, launches Ethos radiotherapy device
Varian Medical (NYSE:VAR) said last week that it invested an unspecified amount in Oncora Medical and launched its Ethos artificial intelligence radiotherapy device. Philadelphia-based Oncora makes software used to plan radiotherapy procedures. Palo Alto, Calif.-based Varian said the partnership with Oncora is aimed at accelerating its software development for radiation oncology. “We envision a world where all […]
Medical linear accelerator makers gain on exemption from Chinese tariffs
Senior editor Nancy Crotti contributed to this report. UPDATED Sept. 16, 2019, with comment from Accuray. Shares in Varian Medical (NYSE:VAR), Accuray (NSDQ:ARAY) and Elekta (STO:EKTA B) gained this week after China added medical linear accelerators to a list of 16 products exempted from its trade war with the U.S. The parties appeared to be edging back to […]
Varian closes $90m microspheres buy from Boston Scientific
Hot on the heels of the $4 billion buyout of BTG by Boston Scientific (NYSE:BSX), Varian (NYSE:VAR) said yesterday that it closed the $90 million acquisition of Boston’s microspheres business. The deal for the drug-eluting and “bland” embolic microsphere business, which includes the Oncozene, Embozene and Embozone Tandem products, was struck to mollify anti-trust regulators about the BTG […]
Boston Scientific to deal microspheres to Varian Medical for $90m
UPDATED July 2, 2019, with financial details, comment from Varian. Looking to mollify anti-trust regulators about its pending $4 billion merger with BTG (LON:BTG), Boston Scientific (NYSE:BSX) said today that it agreed to deal its microsphere assets to Varian Medical (NYSE:VAR) for $90 million. The deal for the drug-eluting and “bland” embolic microsphere business includes Marlborough, Mass.-based Boston […]
Varian closes $283m Cancer Treatment Services buyout
Varian Medical (NYSE:VAR) said today that it closed the $283 million deal to acquire Cancer Treatment Services International and its network of oncology centers on the Indian subcontinent. When it announced the buyout last month, Varian said that it hoped to increase its expertise in cancer care center operations. The deal was financed via a credit facility […]
Varian adds to cancer care portfolio with $185m acquisition
Varian Medical (NYSE:VAR) said this week that it purchased two companies – Endocare and Alicon – to add to its cancer care solutions portfolio. The $185 million acquisition was financed with cash and proceeds from borrowings. Combined, Endocare and Alicon reeled in $30 million in revenues last year. Texas-based Endocare provides hardware and softwre for cryoablation […]
- 1
- 2
- 3
- …
- 15
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube